CXCL10 and rheumatoid arthritis: CXCL10, with an increased expression in synovial cells of patients with RA in response to TNF-α stimulation, interacts with CCR3 in T-cells and mediates an increase in receptor activation of nuclear factor kappa-B ligand (RANKL) expression via the Gαi subunit.